Rein Therapeutics
Pre-market
Advanced
Information
TickerRNTX
Country
United States
CEOMr. Timothy M. Cunningham
Number of Employees
11
Websitereintx.com
SectorHealthcare
IndustryBiotechnology
About
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
Analyst rating
Based on 2 analysts
Buy
Strong buyBuyHoldSellStrong sell
0%100%0%0%0%
The stock market can go up and down. Although investing in stocks historically has given investors a positive return over the long term, there is no guarantee of future returns. This means you run the risk of not getting back the money you invested.